BVNRY

11.9401.08%
HJ

Henrik Juuel

CFO & Executive VP

Mr. Henrik Juuel, M.sc., is the Executive Vice President and Chief Financial Officer (CFO) at Bavarian Nordic A/S since November 1, 2018. He serves as a Director at BioPorto A/S since April 30, 2024 and served as its Interim Chairman of the Board since January 31, 2025 until April 11, 2025 and is its Independent Vice-Chairman of the Board from April 11, 2025. Mr. Juuel served as the Chief Financial Officer and Executive Vice President of Orexo AB since 2013. Mr. Juuel served as Senior Vice President of Orexo AB since 2013. He served as the Chief Financial Officer of GN Store Nord A/S and Virgin Mobile (Central and Eastern Europe. Mr. Juuel served as the Chief Financial Officer at GN ReSound A/S until April 1, 2011. He served at NNE Pharmaplan (formerly Novo Nordisk Engineering) as Chief Financial Officer and Corporate Vice President. Mr. Juuel began his career at Novo Nordisk in 1992 and during his tenure with the company held several senior finance positions in Denmark and abroad. Mr. Juuel also served several positions abroad, including Director of Finance, Europe and Director of Operations and Finance, Europe North. He serves as a Director of Baslev A/S and MetriCorr Aps. Mr. Juuel holds an M.Sc in Economics from the University of Aarhus (Denmark) and an MBA from the University of Leuven (Belgium).

Positions